ESPERION THERAPEUTICS INC. - COMMON STOCK

Esperion Appoints Ben Halladay Chief Financial Officer

16 Nov 2022 16:00:00 By Nasdaq GlobeNewswire

Esperion Virtual Research & Development Day to Highlight Pipeline Programs and Scientific Focus

09 Nov 2022 08:00:01 By Nasdaq GlobeNewswire

Esperion to Participate in Jefferies London Healthcare Conference

02 Nov 2022 08:00:01 By Nasdaq GlobeNewswire

Esperion Reports Third Quarter 2022 Financial Results and Provides Company Update

01 Nov 2022 07:00:01 By Nasdaq GlobeNewswire

Esperion Hosting Virtual Research & Development Day

27 Oct 2022 08:00:01 By Nasdaq GlobeNewswire

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

19 Oct 2022 16:00:00 By Nasdaq GlobeNewswire

Esperion to Report Third Quarter 2022 Financial Results November 1, 2022

17 Oct 2022 08:02:23 By Nasdaq GlobeNewswire

Esperion to Participate in Upcoming September Investor Conferences

30 Aug 2022 08:00:00 By Nasdaq GlobeNewswire

Esperion Announces Bempedoic Acid (NEXLETOL®) Recommended as Oral Non-Statin Therapy for LDL-Cholesterol Lowering in American College of Cardiology Expert Consensus Decision Pathway

26 Aug 2022 08:16:14 By Nasdaq GlobeNewswire

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

04 Aug 2022 16:05:01 By Nasdaq GlobeNewswire

Esperion Reports Second Quarter 2022 Financial Results and Provides Company Update

02 Aug 2022 07:00:02 By Nasdaq GlobeNewswire

Esperion Announces Establishment of Scientific Advisory Board to Support Pipeline and Life Cycle Management

25 Jul 2022 15:00:00 By Nasdaq GlobeNewswire

Esperion to Report Second Quarter 2022 Financial Results August 2, 2022

12 Jul 2022 08:00:02 By Nasdaq GlobeNewswire

Real World Data Analysis Reveals Nearly Half of All Adults at High Risk for ASCVD and Eligible for a Statin Were Not On Any Statin

03 Jun 2022 12:30:00 By Nasdaq GlobeNewswire

Esperion to Participate in the 2022 Jefferies Global Healthcare Conference

02 Jun 2022 08:00:01 By Nasdaq GlobeNewswire

Esperion Announces the Appointment of J. Martin Carroll to its Board of Directors

01 Jun 2022 16:00:00 By Nasdaq GlobeNewswire

Esperion Announces Five Abstracts Accepted for Presentation at the National Lipid Association Scientific Sessions

31 May 2022 08:00:01 By Nasdaq GlobeNewswire

Esperion to Participate in Upcoming H.C. Wainwright Global Investment Conference

17 May 2022 08:00:02 By Nasdaq GlobeNewswire

Esperion Reports First Quarter 2022 Financial Results and Provides Company Update

03 May 2022 07:00:01 By Nasdaq GlobeNewswire

Esperion Announces Publication of CLEAR Harmony Open-Label Extension Study Data for Bempedoic Acid in the American Journal of Cardiology

02 May 2022 08:00:03 By Nasdaq GlobeNewswire